{
    "Trade/Device Name(s)": [
        "Atellica IM Total hCG (ThCG)"
    ],
    "Submitter Information": "Siemens Healthcare Diagnostics Inc.",
    "510(k) Number": "k172322",
    "Predicate Device Reference 510(k) Number(s)": [
        "k925277"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "JHI"
    ],
    "Summary Letter Date": "February 20, 2018",
    "Summary Letter Received Date": "February 21, 2018",
    "Submission Date": "March 28, 2018",
    "Regulation Number(s)": [
        "21 CFR 862.1155"
    ],
    "Regulation Name(s)": [
        "Human chorionic gonadotropin (HCG) test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Human chorionic gonadotropin (hCG)"
    ],
    "Specimen Type(s)": [
        "Serum"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Atellica IM Analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Sandwich immunoassay",
        "Direct chemiluminescence"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Assay",
        "Reagent",
        "Calibrator",
        "Control"
    ],
    "Document Summary": "FDA 510(k) summary for Siemens Atellica IM Total hCG assay for quantitative determination of hCG in serum using the Atellica IM Analyzer",
    "Indications for Use Summary": "For in vitro diagnostic use in the quantitative determination of human chorionic gonadotropin (hCG) in human serum as an aid in the early detection of pregnancy",
    "fda_folder": "Clinical Chemistry"
}